Effect of Oral Anticoagulant (Marcumar) on Prothrombin and Related Components in Blood Coagulation
- 1 May 1957
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 5 (3) , 252-256
- https://doi.org/10.1161/01.res.5.3.252
Abstract
Marcumar has been considered as an excellent anticoagulant for long term management. It was found that the effect of the drug on plasma levels of prothrombin and autoprothrombin I and autoprothrombin II differed from that of the drugs previously studied using the technics described. Autoprothrombin II was not reduced by Marcumar. This clotting factor, autoprothrombin II, has been found to have no influence on the Quick prothrombin time which is the test generally used to follow the effect of anticoagulants on the clotting mechanisms. The two coagulation factors which were found to decrease following the administration of Marcumar, prothrombin and autoprothrombin I, both influence the Quick prothrombin time.Keywords
This publication has 13 references indexed in Scilit:
- Conversion of Prothrombin to Autoprothrombin II (Platelet Cofactor II) and Its Relation to the Blood Clotting MechanismsAmerican Journal of Physiology-Legacy Content, 1956
- QUANTITATIVE CONCEPTS RELATED TO PROTHROMBIN AND AUTOPROTHROMBIN I ACTIVITYCanadian Journal of Biochemistry and Physiology, 1956
- Dextran as a Substitute for Acacia in Assay of Plasma ProthrombinAmerican Journal of Clinical Pathology, 1955
- Plasma Thromboplastin Component (PTC) Deficiency Produced by Prolonged Administration of Prothrombopenic Anticoagulants.Experimental Biology and Medicine, 1955
- Bovine Platelets in Large Quantities Properties and Activities Concerned With HemostasisAmerican Journal of Physiology-Legacy Content, 1954
- Use of Purified Prothrombin in the Study of Hemophilia and Plasma Thromboplastin Component (PTC) DeficiencyJournal of Applied Physiology, 1954
- Plasma Throinboplastin Component (PTC) Deficiency: A New Disease Resembling HemophiliaExperimental Biology and Medicine, 1952
- Co-thromboplastin AssayAmerican Journal of Clinical Pathology, 1949
- FACTORS WHICH INFLUENCE THE ACTIVITY OF PURIFIED THROMBINAmerican Journal of Physiology-Legacy Content, 1942
- Imidazole Buffer: Its Use in Blood Clotting Studies.Experimental Biology and Medicine, 1940